Literature DB >> 21768636

Preliminary results after reconstruction of bony defects of the proximal humerus with an allograft-resurfacing composite.

P Ruggieri1, A F Mavrogenis, G Guerra, M Mercuri.   

Abstract

We retrospectively studied 14 patients with proximal and diaphyseal tumours and disappearing bone (Gorham's) disease of the humerus treated with wide resection and reconstruction using an allograft-resurfacing composite (ARC). There were ten women and four men, with a mean age of 35 years (8 to 69). At a mean follow-up of 25 months (10 to 89), two patients had a fracture of the allograft. In one of these it was revised with a similar ARC and in the other with an intercalary prosthesis. A further patient had an infection and a fracture of the allograft that was revised with a megaprosthesis. In all patients with an ARC, healing of the ARC-host bone interface was observed. One patient had failure of the locking mechanism of the total elbow replacement. The mean post-operative Musculoskeletal Tumor Society score for the upper extremity was 77% (46.7% to 86.7%), which represents good and excellent results; one patient had a poor result (46.7%). In the short term ARC effectively relieves pain and restores shoulder function in patients with wide resection of the proximal humerus. Fracture and infection remain significant complications.

Entities:  

Mesh:

Year:  2011        PMID: 21768636     DOI: 10.1302/0301-620X.93B8.26011

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  13 in total

Review 1.  Megaprosthesis versus Allograft Prosthesis Composite for massive skeletal defects.

Authors:  Deepak Gautam; Rajesh Malhotra
Journal:  J Clin Orthop Trauma       Date:  2017-09-25

Review 2.  State-of-the-art approach for bone sarcomas.

Authors:  Andreas F Mavrogenis; Andrea Angelini; Christos Vottis; Emanuela Palmerini; Eugenio Rimondi; Giuseppe Rossi; Panayiotis J Papagelopoulos; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-03

3.  What does vanishing bone disease look like?

Authors:  Jarrad Stevens; Hannah Flower; James T Patton
Journal:  BMJ Case Rep       Date:  2018-03-22

4.  Proximal humerus allograft prosthetic composites: technique, outcomes, and pearls and pitfalls.

Authors:  Santiago A Lozano-Calderón; Neal Chen
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

Review 5.  Megaprosthesis Versus Allograft Prosthesis Composite for the Management of Massive Skeletal Defects: A Meta-Analysis of Comparative Studies.

Authors:  Deepak Gautam; Nitish Arora; Saurabh Gupta; Jaiben George; Rajesh Malhotra
Journal:  Curr Rev Musculoskelet Med       Date:  2021-04-17

Review 6.  Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review.

Authors:  Teun Teunis; Sjoerd P F T Nota; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón
Journal:  Clin Orthop Relat Res       Date:  2014-01-28       Impact factor: 4.176

7.  What Is the Survival and Function of Modular Reverse Total Shoulder Prostheses in Patients Undergoing Tumor Resections in Whom an Innervated Deltoid Muscle Can Be Preserved?

Authors:  Giulia Trovarelli; Alessandro Cappellari; Andrea Angelini; Elisa Pala; Pietro Ruggieri
Journal:  Clin Orthop Relat Res       Date:  2019-11       Impact factor: 4.176

Review 8.  What is the Optimal Reconstruction Option after the Resection of Proximal Humeral Tumors? A Systematic Review.

Authors:  Andrew Dubina; Brian Shiu; Mohit Gilotra; S Ashfaq Hasan; Daniel Lerman; Vincent Y Ng
Journal:  Open Orthop J       Date:  2017-03-22

9.  Plate-prosthesis composite reconstruction after large segmental resection of proximal humeral tumors: A retrospective comparative study.

Authors:  Ran Wei; Wei Guo; Rongli Yang; Xiaodong Tang; Yi Yang; Tao Ji
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

10.  Allograft reconstruction for the treatment of musculoskeletal tumors of the upper extremity.

Authors:  Luis A Aponte-Tinao; Miguel A Ayerza; D Luis Muscolo; German L Farfalli
Journal:  Sarcoma       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.